BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7239185)

  • 1. Brachytherapy renaissance.
    Goffinet DR; Martinez A; Pooler D; Palos B; Cox R
    Front Radiat Ther Oncol; 1980; 15():43-57. PubMed ID: 7239185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Brachycurie therapy of tumors--renaissance of a radio-oncologic method].
    Sauer R; Thiel HJ; Müller R
    Fortschr Med; 1982 Jun; 100(22):1047-53. PubMed ID: 7106669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachytherapy and local control.
    Sannazzari GL; Ruo Redda MG; Rampino M; Verna R
    Rays; 1998; 23(3):427-38. PubMed ID: 9932464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interstitial radiotherapy].
    Hammer J
    Wien Med Wochenschr; 1983 Jun; 133(12):307-9. PubMed ID: 6684364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demystifying care of patients with radioactive implants.
    Hassey K
    Am J Nurs; 1985 Jul; 85(7):788-92. PubMed ID: 3848274
    [No Abstract]   [Full Text] [Related]  

  • 6. New approaches to brachytherapy.
    Hilaris BS; Nori D; Anderson LL
    Important Adv Oncol; 1987; ():237-61. PubMed ID: 3331382
    [No Abstract]   [Full Text] [Related]  

  • 7. [Physical brachytherapy planning].
    Muskalla K
    Praxis (Bern 1994); 2001 Sep; 90(36):1532-43. PubMed ID: 11593909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P; Thissen B; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103.
    Rivard MJ; Butler WM; Devlin PM; Hayes JK; Hearn RA; Lief EP; Meigooni AS; Merrick GS; Williamson JF
    Brachytherapy; 2007; 6(1):34-7. PubMed ID: 17284383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brachytherapy in the treatment of prostatic carcinoma].
    Casas F; Ferrer F; Casals J; Farrus B; Rovirosa A; Biete A
    Actas Urol Esp; 1995 Sep; 19(8):662-9. PubMed ID: 8669336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
    Stone NN; Stock RG
    Brachytherapy; 2003; 2(1):32-9. PubMed ID: 15062161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative versus interstitial radiotherapy: a comparison of morbidity in the head and neck.
    Close LG; Morrish TN; Nguyen P
    Laryngoscope; 1993 Mar; 103(3):231-46. PubMed ID: 8441310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
    Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
    Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
    Potters L; Calugaru E; Jassal A; Presser J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1014-9. PubMed ID: 16682144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of brachytherapy, external beam irradiation and hormonal therapy on prostate volume.
    Stone NN; Stock RG
    J Urol; 2007 Mar; 177(3):925-8. PubMed ID: 17296377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
    Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of pulmonary migration of permanent interstitial sources in patients undergoing prostate brachytherapy.
    Stone NN; Stock RG
    Urology; 2005 Jul; 66(1):119-23. PubMed ID: 15992909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
    Dicker AP; Lin CC; Leeper DB; Waterman FM
    Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Technique of intraoperative planning in prostatic brachytherapy with permanent implants of 125I or 103Pd].
    Prada Gómez PJ; Juan Rijo G; Hevia Suarez M; Abascal García JM; Abascal García R
    Arch Esp Urol; 2002 Dec; 55(10):1217-23; discussion 1223-4. PubMed ID: 12611219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-year experience of interstitial permanent brachytherapy for Japanese men with localized prostate cancer.
    Ishiyama H; Satoh T; Kitano M; Tsumura H; Kotani S; Okusa H; Uemae M; Baba S; Hayakawa K
    Jpn J Clin Oncol; 2008 Jul; 38(7):469-73. PubMed ID: 18577509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.